SCHEMBL8934624

SCHEMBL8934624

COc1ccc(-c2c(-c3ccccc3)c(=O)oc3cc(C)ccc23)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.60
NPC1 O15118 3/20 0.57
ALDH1A1 P00352 4/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
CYP19A1 P11511 3/20 0.52
MAPT P10636 3/20 0.51
ATM Q13315 1/20 0.51
KDM4E B2RXH2 3/20 0.51
LMNA P02545 2/20 0.51
RAB9A P51151 2/20 0.51
POLB P06746 1/20 0.51
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
TNKS O95271 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
STAT1 P42224 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13819275 0.92 ALDH1A1 (0.63) MAOBNPC1ALDH1A1CYP1A2CYP2C9
SCHEMBL7117813 0.91 ALDH1A1 (0.64) MAOBNPC1ALDH1A1CYP1A2CYP2C9
SCHEMBL7124521 0.90 MAOB (0.71) MAOBNPC1ALDH1A1CYP1A2CYP2C9
SCHEMBL31511407 0.90 MAOB (0.71) MAOBNPC1ALDH1A1CYP1A2CYP2C9
SCHEMBL7117556 0.88 ALDH1A1 (0.67) MAOBNPC1ALDH1A1CYP1A2CYP2C9
SCHEMBL5084963 0.86 NPC1 (0.73) MAOBNPC1ALDH1A1CYP1A2CYP2C9
SCHEMBL31511409 0.85 MAOB (0.72) MAOBNPC1ALDH1A1CYP1A2CYP2C9
SCHEMBL7463411 0.85 MAOB (0.72) MAOBNPC1ALDH1A1CYP1A2CYP2C9
SCHEMBL15103561 0.85 CA1 (0.63) MAOBNPC1ALDH1A1CYP1A2CYP2C9
SCHEMBL7115073 0.84 ALDH1A1 (0.56) MAOBNPC1ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed